help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published ahead of print on July 7, 2005, doi:10.1164/rccm.200503-319OC

Am. J. Respir. Crit. Care Med., Volume 172, Number 9, November 2005, 1097-1104

A more recent version of this article appeared on November 1, 2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200503-319OCv1
172/9/1097    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takabatake, N.
Right arrow Articles by Kubota, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takabatake, N.
Right arrow Articles by Kubota, I.

Submitted on March 1, 2005
Accepted on June 30, 2005

A Novel Polymorphism in Secretory Phospholipase A2-IID is Associated with Body Weight Loss in COPD

Noriaki Takabatake1, Makoto Sata1*, Sumito Inoue1, Yoko Shibata1, Shuichi Abe1, Toshihiro Wada1, Jun-ichi Machiya1, Guijin Ji2, Tadashi Matsuura2, Yasuchika Takeishi1, Masaaki Muramatsu2, and Isao Kubota1

1 First Department of Internal Medicine, Yamagata University School of Medicine, Yamagata, Japan, 2 HuBit genomix. Inc., Tokyo, Japan

* To whom correspondence should be addressed. E-mail: msata{at}med.id.yamagata-u.ac.jp.

Rationale: Chronic and systemic inflammation, a potential cause of body weight loss in patients with COPD, may be associated with the pro-inflammatory properties of secretory phospholipases A2 (sPLA2s), especially the group II subfamily sPLA2s. Objectives: We tested our hypothesis that the individual susceptibility to body weight loss in patients with COPD is attributed to the genetic variances of this sPLA2s gene region. Methods: A total of twelve SNPs encompassing the sPLA2s gene region were determined in 276 male patients with COPD. Measurements and Main Results: We first analyzed our patients whose BMI are the bottom one hundred [BMI (kg/m2); 17.13 ± 1.29], and are the top one hundred (23.83 ± 1.98) in relation to SNPs. Both of Fisher's exact test [odds ratio (95% CI): 2.36 (1.34 - 4.18), p = 0.004] and logistic regression analysis [2.10 (1.13 - 3.90), p = 0.019] showed statistical significance between one SNP (NCBI SNP reference: rs584367) and the reduction of BMI in the recessive model in patients with COPD. Using the whole patients, a significant difference between the values of BMI (log transformed) of mutant group (CT + TT) and that of non-mutant group (CC) of this SNP [mean (SE): 1.293 (0.005) vs. 1.317 (0.006), p = 0.003] was found after adjustment with age, smoking habit, and pulmonary function (ANCOVA). Importantly, this SNP causes amino acids change in sPLA2-IID protein (Gly80Ser). Conclusions: These results suggest that sPLA2-IID may be one of the susceptibility genes that contribute to body weight loss in patients with COPD.


Key words: SNPs, sPLA2-IID gene, body weight loss, COPD, ANCOVA




This article has been cited by other articles:


Home page
Infect. Immun.Home page
B. P. Hurley and B. A. McCormick
Multiple Roles of Phospholipase A2 during Lung Infection and Inflammation
Infect. Immun., June 1, 2008; 76(6): 2259 - 2272.
[Full Text] [PDF]


Home page
ThoraxHome page
H. Makita, Y. Nasuhara, K. Nagai, Y. Ito, M. Hasegawa, T. Betsuyaku, Y. Onodera, N. Hizawa, M. Nishimura, and the Hokkaido COPD Cohort Study Group
Characterisation of phenotypes based on severity of emphysema in chronic obstructive pulmonary disease
Thorax, November 1, 2007; 62(11): 932 - 937.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
N. Takabatake, Y. Shibata, S. Abe, T. Wada, J.-i. Machiya, A. Igarashi, Y. Tokairin, G. Ji, H. Sato, M. Sata, et al.
A Single Nucleotide Polymorphism in the CCL1 Gene Predicts Acute Exacerbations in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., October 15, 2006; 174(8): 875 - 885.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
L. M. Fabbri, F. Luppi, B. Beghe, and K. F. Rabe
Update in chronic obstructive pulmonary disease 2005.
Am. J. Respir. Crit. Care Med., May 15, 2006; 173(10): 1056 - 1065.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2005 American Thoracic Society
  ATS Best of the Web